Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterolog
Go back to Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterolog| (NASDAQ: JAGX) | Delayed: 2.56 -0.05 (1.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.61 | 52 Week High | $4.60 | |||
| Open | $2.50 | 52 Week Low | $0.81 | |||
| Day High | $2.64 | P/E | N/A | |||
| Day Low | $2.46 | EPS | $0.00 | |||
| Volume | 102,642 | |||||
